Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.01 billion.
Market Cap
1.14T
Revenue
110.01B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.56B | -0.13% | 444,864 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.69B | -0.86% | 530,977 | 14.92B |
| 3 | ARGX | argenx SE | 52.11B | -0.59% | 108,463 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.99B | -1.82% | 403,081 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.15B | 0.84% | 2,138,102 | - |
| 6 | ONC | BeOne Medicines AG | 32.31B | 0.02% | 89,316 | 5.70B |
| 7 | RPRX | Royalty Pharma plc | 31.60B | 0.73% | 1,538,527 | 2.44B |
| 8 | BNTX | BioNTech SE | 24.53B | 3.81% | 623,471 | 3.23B |
| 9 | INSM | Insmed Incorporated | 23.37B | -0.51% | 1,114,022 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 21.72B | 1.07% | 2,204,120 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.48B | - | 521,178 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.23B | 1.89% | 2,721,802 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.27B | -1.92% | 1,584,594 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.63B | -0.97% | 651,243 | 4.44B |
| 15 | SMMT | Summit Therapeutics Inc. | 13.97B | 3.42% | 3,696,064 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.86B | -6.03% | 738,219 | 998.25M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.15B | -1.94% | 1,277,726 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.85B | -0.66% | 684,392 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.80B | 0.18% | 467,468 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.99B | 0.03% | 366,380 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.48B | -3.48% | 166,822 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.91B | -2.01% | 545,257 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.77B | 5.67% | 1,194,855 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.54B | 2.53% | 1,147,681 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.43B | - | 678,393 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.51B | -3.23% | 133,205 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.08B | -0.74% | 98,447 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.68B | 0.61% | 273,912 | - |
| 29 | TECH | Bio-Techne Corporation | 8.12B | 2.05% | 818,363 | 1.21B |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.96B | -1.57% | 614,710 | 1.51B |
| 31 | IBRX | ImmunityBio, Inc. | 7.83B | -3.11% | 9,138,888 | 140.98M |
| 32 | CORT | Corcept Therapeutics Incorporated | 7.45B | 1.46% | 291,653 | 769.10M |
| 33 | PCVX | Vaxcyte, Inc. | 7.36B | -0.12% | 472,462 | - |
| 34 | IMVT | Immunovant, Inc. | 6.79B | -1.22% | 598,661 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.72B | 0.27% | 261,717 | 51.48M |
| 36 | CELC | Celcuity Inc. | 6.54B | 2.43% | 629,164 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -1.20% | 227,029 | 74.06M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.29B | 0.46% | 145,669 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | -1.95% | 198,764 | 217.17M |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 1.95% | 595,114 | 569.61M |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.14% | 442,670 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.09B | 3.31% | 273,767 | 827.11M |
| 43 | APGE | Apogee Therapeutics, Inc. | 6.03B | 3.42% | 431,184 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 6.00B | -0.79% | 904,332 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.97B | 0.06% | 319,038 | - |
| 46 | BLTE | Belite Bio, Inc | 5.60B | -3.80% | 394,380 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.45B | -0.88% | 405,089 | 700.35M |
| 48 | CGON | CG Oncology, Inc. | 5.44B | 1.57% | 369,250 | 5.07M |
| 49 | CRSP | CRISPR Therapeutics AG | 5.38B | -0.99% | 893,038 | 4.10M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 0.11% | 695,503 | 7.50M |
| 51 | LEGN | Legend Biotech Corporation | 5.05B | -3.79% | 1,465,786 | 1.14B |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.02B | 1.17% | 323,602 | 1.34M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.73B | 0.30% | 814,657 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | -1.07% | 55,303 | 274.48M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.37B | -1.59% | 684,450 | 536.20M |
| 56 | MANE | Veradermics, Incorporated | 4.08B | -5.19% | 656,276 | - |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.95B | -4.71% | 1,384,014 | 22.57M |
| 58 | ERAS | Erasca, Inc. | 3.93B | 3.61% | 2,443,381 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.13% | 1,133,410 | 596.96M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.78B | 1.15% | 818,902 | - |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.76B | -1.00% | 789,492 | 18.07M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | 0.28% | 634,311 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.63B | 1.31% | 414,688 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.53B | 0.93% | 576,043 | - |
| 65 | DNLI | Denali Therapeutics Inc. | 3.35B | 0.81% | 708,090 | - |
| 66 | BEAM | Beam Therapeutics Inc. | 3.33B | 2.13% | 596,037 | 164.01M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.20B | 4.36% | 635,018 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.17B | -0.68% | 76,380 | 803.79M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.16B | 2.66% | 1,102,511 | 236.00M |
| 70 | RLAY | Relay Therapeutics, Inc. | 3.11B | 2.66% | 1,059,163 | 10.68M |
| 71 | TNGX | Tango Therapeutics, Inc. | 3.05B | 5.30% | 738,492 | 56.99M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.96B | -0.35% | 227,953 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 2.80B | -1.92% | 210,834 | - |
| 74 | ALMS | Alumis Inc. | 2.75B | 0.75% | 300,550 | 8.40M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.68B | 0.09% | 427,756 | 415.62M |
| 76 | IRON | Disc Medicine, Inc. | 2.68B | -0.92% | 164,511 | - |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.64B | 3.15% | 1,096,591 | - |
| 78 | IDYA | IDEAYA Biosciences, Inc. | 2.62B | 1.57% | 286,430 | 225.27M |
| 79 | VERA | Vera Therapeutics, Inc. | 2.60B | 1.12% | 457,615 | - |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | -0.19% | 323,336 | - |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 0.20% | 313,983 | 535.08M |
| 82 | IMNM | Immunome, Inc. | 2.50B | -2.22% | 340,038 | 4.02M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.48B | -0.47% | 98,690 | 865.00K |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.43B | -1.89% | 338,444 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | 3.18% | 625,586 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.35B | 4.04% | 141,839 | - |
| 87 | NKTR | Nektar Therapeutics | 2.18B | -0.63% | 462,553 | 55.63M |
| 88 | PHVS | Pharvaris N.V. | 2.10B | 1.17% | 126,227 | - |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.04B | -0.42% | 322,958 | - |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 0.87% | 760,088 | 52.04M |
| 91 | NBTX | Nanobiotix S.A. | 2.01B | -0.24% | 32,769 | 38.27M |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.00B | 3.06% | 361,445 | - |
| 93 | MESO | Mesoblast Limited | 1.99B | 4.81% | 96,171 | 65.38M |
| 94 | ZLAB | Zai Lab Limited | 1.99B | -4.22% | 475,569 | 453.28M |
| 95 | NTLA | Intellia Therapeutics, Inc. | 1.97B | 3.14% | 2,813,198 | 66.09M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -1.04% | 411,328 | 298.30M |
| 97 | SION | Sionna Therapeutics, Inc. | 1.94B | 0.28% | 171,742 | - |
| 98 | VRDN | Viridian Therapeutics, Inc. | 1.94B | 0.52% | 465,912 | 70.92M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.92B | -2.50% | 167,135 | 32.08M |
| 100 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 4.51% | 19,980,661 | 66.41M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 3.76% | 1,387,729 | 2.18B |
| 102 | ABCL | AbCellera Biologics Inc. | 1.89B | 8.03% | 6,604,232 | 79.21M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.89B | 2.65% | 892,400 | 509.86M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 1.87B | -0.91% | 102,856 | 20.00M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.49% | 79,780 | 1.20B |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.85B | 1.05% | 345,251 | 71.78M |
| 107 | AAPG | Ascentage Pharma Group International | 1.84B | -0.03% | 14,614 | 82.08M |
| 108 | ZYME | Zymeworks Inc. | 1.83B | -1.53% | 223,546 | 81.26M |
| 109 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 0.38% | 361,392 | 899.11M |
| 110 | NVAX | Novavax, Inc. | 1.81B | 6.83% | 3,817,102 | 596.34M |
| 111 | IOVA | Iovance Biotherapeutics, Inc. | 1.79B | -6.51% | 11,184,118 | 285.61M |
| 112 | AGIO | Agios Pharmaceuticals, Inc. | 1.78B | -1.61% | 596,098 | 66.05M |
| 113 | QURE | uniQure N.V. | 1.75B | 11.71% | 2,048,963 | 18.09M |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.75B | 3.74% | 357,372 | 11.13M |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -0.25% | 287,582 | 217.17M |
| 116 | VCEL | Vericel Corporation | 1.73B | -1.17% | 115,966 | 292.09M |
| 117 | SLS | SELLAS Life Sciences Group, Inc. | 1.72B | 0.60% | 16,955,636 | - |
| 118 | OCS | Oculis Holding AG | 1.72B | -2.19% | 288,689 | 1.51M |
| 119 | BHVN | Biohaven Ltd. | 1.70B | 10.16% | 2,823,333 | - |
| 120 | GENB | Generate Biomedicines, Inc. | 1.69B | 0.65% | 272,922 | 30.30M |
| 121 | PVLA | Palvella Therapeutics, Inc. | 1.69B | 1.62% | 59,443 | - |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | -1.18% | 905,611 | 7.47M |
| 123 | ATAI | AtaiBeckley Inc. | 1.67B | 3.40% | 2,206,026 | 3.49M |
| 124 | VIR | Vir Biotechnology, Inc. | 1.65B | 2.57% | 1,427,856 | 65.50M |
| 125 | NUVB | Nuvation Bio Inc. | 1.65B | -0.21% | 1,542,385 | 143.05M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.65B | 0.46% | 284,660 | 42.95M |
| 127 | GHRS | GH Research PLC | 1.64B | 7.09% | 165,670 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.62B | -2.63% | 190,908 | 232.39M |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.59B | 4.21% | 107,849 | - |
| 130 | INVA | Innoviva, Inc. | 1.59B | -1.60% | 377,789 | 420.69M |
| 131 | PGEN | Precigen, Inc. | 1.58B | -1.44% | 2,391,545 | 31.60M |
| 132 | IMTX | Immatics N.V. | 1.53B | -0.66% | 110,195 | 43.00M |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.52B | -0.55% | 124,070 | 1.30M |
| 134 | MBX | MBX Biosciences, Inc. | 1.51B | -0.75% | 210,902 | - |
| 135 | ARDX | Ardelyx, Inc. | 1.51B | -2.48% | 1,296,953 | 427.68M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.47B | 0.59% | 92,638 | 20.00M |
| 137 | IMCR | Immunocore Holdings plc | 1.46B | -0.72% | 189,075 | 412.81M |
| 138 | FTRE | Fortrea Holdings Inc. | 1.46B | 2.93% | 548,309 | 2.71B |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.43B | 0.26% | 69,022 | - |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.21% | 702,499 | 114.48M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 12.61% | 536,036 | - |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.41B | 3.32% | 406,124 | - |
| 143 | URGN | UroGen Pharma Ltd. | 1.38B | -1.43% | 375,241 | 140.49M |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 0.87% | 216,508 | - |
| 145 | SEPN | Septerna, Inc. | 1.36B | -2.77% | 100,756 | 72.26M |
| 146 | SVRA | Savara Inc. | 1.31B | 1.38% | 617,117 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.28B | 2.47% | 953,607 | 71.80M |
| 148 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.26B | 4.85% | 1,643,349 | 204.73M |
| 149 | COAG | Hemab Therapeutics Holdings, Inc. | 1.24B | 0.29% | 68,563 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.21B | 2.22% | 131,307 | - |
| 151 | MNKD | MannKind Corporation | 1.18B | 4.67% | 13,190,138 | 360.78M |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.18B | 0.32% | 166,313 | 10.00M |
| 153 | EYPT | EyePoint, Inc. | 1.17B | 3.70% | 317,913 | 7.61M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.15B | 1.52% | 58,833 | 8.28M |
| 155 | OLMA | Olema Pharmaceuticals, Inc. | 1.12B | 0.24% | 507,733 | - |
| 156 | DBVT | DBV Technologies S.A. | 1.11B | 0.18% | 216,342 | 5.74M |
| 157 | IVA | Inventiva S.A. | 1.10B | -4.40% | 47,597 | 7.94M |
| 158 | ABSI | Absci Corporation | 1.08B | 14.14% | 6,093,994 | 1.84M |
| 159 | JBIO | Jade Biosciences, Inc. | 1.07B | 3.65% | 308,375 | - |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -1.76% | 1,066,198 | - |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 991.63M | 5.05% | 884,544 | - |
| 162 | LXRX | Lexicon Pharmaceuticals, Inc. | 977.03M | -0.45% | 890,673 | 69.64M |
| 163 | SPTX | Seaport Therapeutics, Inc. | 965.37M | -3.16% | 37,381 | - |
| 164 | MGTX | MeiraGTx Holdings plc | 962.21M | 3.90% | 498,934 | 79.76M |
| 165 | PHAR | Pharming Group N.V. | 949.84M | -2.20% | 8,730 | 369.49M |
| 166 | ABUS | Arbutus Biopharma Corporation | 918.55M | 1.09% | 1,184,509 | 191.45M |
| 167 | SPRY | ARS Pharmaceuticals, Inc. | 912.60M | -2.23% | 1,089,413 | 98.99M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 902.67M | 3.20% | 1,941,342 | - |
| 169 | DRTS | Alpha Tau Medical Ltd. | 902.66M | -1.18% | 479,009 | - |
| 170 | KURA | Kura Oncology, Inc. | 898.84M | 1.55% | 860,681 | 71.64M |
| 171 | JANX | Janux Therapeutics, Inc. | 895.25M | -0.41% | 563,762 | 13.73M |
| 172 | SANA | Sana Biotechnology, Inc. | 887.75M | 1.92% | 2,290,022 | - |
| 173 | XNCR | Xencor, Inc. | 885.99M | -0.17% | 223,926 | 97.36M |
| 174 | ANNX | Annexon, Inc. | 880.65M | 0.09% | 911,322 | - |
| 175 | DRUG | Bright Minds Biosciences Inc. | 872.67M | 0.16% | 128,145 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 834.13M | -0.19% | 228,888 | 109.78M |
| 177 | AVTX | Avalo Therapeutics, Inc. | 832.11M | -1.86% | 479,209 | 59.00K |
| 178 | EVMN | Evommune, Inc. | 826.62M | -1.63% | 83,828 | 10.00M |
| 179 | AURA | Aura Biosciences, Inc. | 821.73M | -0.67% | 161,297 | - |
| 180 | VOR | Vor Biopharma Inc. | 813.06M | -0.03% | 229,689 | - |
| 181 | ODTX | Odyssey Therapeutics, Inc. | 812.34M | -3.91% | 77,133 | 2.98M |
| 182 | LBRX | LB Pharmaceuticals Inc | 807.82M | 2.32% | 63,889 | - |
| 183 | GERN | Geron Corporation | 805.11M | 0.40% | 5,300,868 | 196.12M |
| 184 | OMER | Omeros Corporation | 796.13M | -1.35% | 618,178 | 9.89M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 790.26M | -2.16% | 792,565 | 35.54M |
| 186 | PHAT | Phathom Pharmaceuticals, Inc. | 787.15M | -3.97% | 704,759 | 204.89M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 754.67M | -0.76% | 316,012 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 747.26M | -3.78% | 6,198,179 | 22.00K |
| 189 | SLDB | Solid Biosciences Inc. | 730.50M | 4.95% | 452,976 | - |
| 190 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 716.96M | 1.24% | 76,351 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 716.48M | 1.09% | 67,013 | - |
| 192 | CBIO | Crescent Biopharma, Inc. | 715.75M | 0.33% | 288,416 | 11.88M |
| 193 | REPL | Replimune Group, Inc. | 715.08M | 85.04% | 44,274,131 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 694.76M | 0.94% | 199,499 | - |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 689.87M | 2.37% | 1,140,840 | 122.29M |
| 196 | CRMD | CorMedix Inc. | 662.92M | 0.36% | 493,457 | 400.05M |
| 197 | SGP | SpyGlass Pharma, Inc. | 657.83M | -0.81% | 20,838 | - |
| 198 | DSGN | Design Therapeutics, Inc. | 651.43M | -2.89% | 351,204 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 634.77M | -0.55% | 408,752 | 8.37M |
| 200 | PRME | Prime Medicine, Inc. | 632.16M | 2.94% | 1,809,535 | 4.03M |
| 201 | DNA | Ginkgo Bioworks Holdings, Inc. | 630.05M | 1.96% | 607,836 | 151.40M |
| 202 | CABA | Cabaletta Bio, Inc. | 617.16M | 0.40% | 1,399,460 | - |
| 203 | CADL | Candel Therapeutics, Inc. | 615.47M | 3.83% | 656,551 | - |
| 204 | IMMX | Immix Biopharma, Inc. | 611.37M | -0.90% | 414,607 | - |
| 205 | ALT | Altimmune, Inc. | 598.01M | 0.16% | 953,817 | 36.00K |
| 206 | VALN | Valneva SE | 590.53M | -1.11% | 43,369 | 180.25M |
| 207 | EIKN | Eikon Therapeutics, Inc. | 578.47M | 3.74% | 122,628 | - |
| 208 | TECX | Tectonic Therapeutic, Inc. | 573.06M | 1.98% | 126,419 | - |
| 209 | ARVN | Arvinas, Inc. | 572.95M | 0.45% | 317,967 | 89.40M |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 564.31M | 1.50% | 155,592 | 299.77M |
| 211 | ASMB | Assembly Biosciences, Inc. | 557.86M | 1.51% | 39,356 | 71.10M |
| 212 | PROK | ProKidney Corp. | 555.79M | 1.66% | 549,684 | 889.00K |
| 213 | ACHV | Achieve Life Sciences, Inc. | 555.39M | 2.08% | 542,864 | - |
| 214 | AGMB | AgomAb Therapeutics NV | 553.05M | -2.69% | 12,889 | - |
| 215 | TRAX | First Tracks Biotherapeutics, Inc. | 552.87M | 0.16% | 137,400 | - |
| 216 | MDXG | MiMedx Group, Inc. | 551.84M | 0.95% | 375,112 | 389.42M |
| 217 | CLYM | Climb Bio, Inc. | 543.61M | 0.35% | 197,127 | - |
| 218 | GYRE | Gyre Therapeutics, Inc. | 539.09M | 2.79% | 38,013 | 117.05M |
| 219 | PRTA | Prothena Corporation plc | 528.77M | 1.20% | 214,432 | 57.94M |
| 220 | EDIT | Editas Medicine, Inc. | 525.61M | -0.15% | 2,493,660 | 38.69M |
| 221 | XOMA | XOMA Royalty Corporation | 523.34M | 0.07% | 25,027 | 48.56M |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 522.98M | -0.12% | 372,299 | - |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 521.72M | 11.26% | 2,904,966 | 88.24M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 502.10M | 0.90% | 47,355 | - |
| 225 | AUTL | Autolus Therapeutics plc | 499.02M | 5.93% | 1,651,067 | 92.62M |
| 226 | CCCC | C4 Therapeutics, Inc. | 485.90M | 20.49% | 4,250,612 | 34.86M |
| 227 | STRO | Sutro Biopharma, Inc. | 485.69M | -1.06% | 60,620 | 102.48M |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 482.67M | -2.30% | 158,390 | - |
| 229 | ANL | Adlai Nortye Ltd. | 481.20M | 6.46% | 82,320 | 5.00M |
| 230 | FBRX | Forte Biosciences, Inc. | 475.76M | -6.26% | 185,766 | - |
| 231 | OVID | Ovid Therapeutics Inc. | 472.39M | 3.41% | 1,021,970 | 7.12M |
| 232 | OCGN | Ocugen, Inc. | 468.85M | -1.77% | 2,976,932 | 4.47M |
| 233 | FULC | Fulcrum Therapeutics, Inc. | 465.10M | 2.35% | 144,373 | 80.00M |
| 234 | UPB | Upstream Bio, Inc. | 456.58M | 0.84% | 150,115 | 3.32M |
| 235 | STTK | Shattuck Labs, Inc. | 455.48M | -0.50% | 711,149 | 1.00M |
| 236 | MNPR | Monopar Therapeutics Inc. | 445.64M | 3.25% | 83,320 | - |
| 237 | SGMT | Sagimet Biosciences Inc. | 445.23M | -0.83% | 198,972 | - |
| 238 | NGNE | Neurogene Inc. | 438.50M | 0.91% | 31,416 | 925.00K |
| 239 | ADCT | ADC Therapeutics SA | 434.99M | -0.87% | 210,110 | 79.18M |
| 240 | CMPX | Compass Therapeutics, Inc. | 434.91M | 0.21% | 2,834,261 | 850.00K |
| 241 | IPSC | Century Therapeutics, Inc. | 425.64M | -1.05% | 508,284 | 109.16M |
| 242 | VTVT | vTv Therapeutics Inc. | 414.17M | -0.37% | 12,802 | 36.84M |
| 243 | LXEO | Lexeo Therapeutics, Inc. | 406.74M | 1.97% | 233,828 | - |
| 244 | LYEL | Lyell Immunopharma, Inc. | 406.13M | 3.42% | 27,275 | 31.00K |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 401.80M | 2.90% | 468,406 | 9.01M |
| 246 | ZURA | Zura Bio Limited | 401.68M | 0.80% | 248,059 | - |
| 247 | BNTC | Benitec Biopharma Inc. | 401.43M | 1.08% | 40,927 | - |
| 248 | OABI | OmniAb, Inc. | 394.33M | - | 189,932 | 28.94M |
| 249 | VNDA | Vanda Pharmaceuticals Inc. | 390.58M | -2.18% | 407,393 | 217.78M |
| 250 | VSTM | Verastem, Inc. | 386.64M | 2.56% | 790,443 | 49.59M |
| 251 | PRLD | Prelude Therapeutics Incorporated | 386.22M | -2.29% | 155,474 | 16.72M |
| 252 | ARTV | Artiva Biotherapeutics, Inc. | 384.33M | 3.94% | 560,231 | 251.00K |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 382.96M | -0.45% | 55,257 | 69.21M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 379.20M | -5.59% | 112,825 | - |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 374.13M | -1.16% | 126,311 | - |
| 256 | RGNX | REGENXBIO Inc. | 365.50M | 2.61% | 536,091 | 87.82M |
| 257 | LRMR | Larimar Therapeutics, Inc. | 365.34M | 0.29% | 496,493 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 364.95M | -0.97% | 104,851 | 227.18M |
| 259 | IMRX | Immuneering Corporation | 362.95M | 10.87% | 1,695,678 | - |
| 260 | IFRX | InflaRx N.V. | 357.19M | 1.89% | 399,839 | 33.82K |
| 261 | PALI | Palisade Bio, Inc. | 352.43M | 2.18% | 333,002 | - |
| 262 | NMRA | Neumora Therapeutics, Inc. | 349.85M | 1.86% | 557,113 | - |
| 263 | RZLT | Rezolute, Inc. | 348.92M | 2.14% | 671,583 | - |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 345.63M | 0.61% | 233,809 | 51.00M |
| 265 | NAUT | Nautilus Biotechnology, Inc. | 344.38M | 4.23% | 334,360 | - |
| 266 | IVVD | Invivyd, Inc. | 337.33M | 1.33% | 2,544,302 | 55.87M |
| 267 | ABEO | Abeona Therapeutics Inc. | 335.99M | 1.99% | 372,310 | 14.54M |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 335.15M | 0.97% | 105,512 | - |
| 269 | LCTX | Lineage Cell Therapeutics, Inc. | 335.03M | 1.05% | 278,937 | 14.78M |
| 270 | RCKT | Rocket Pharmaceuticals, Inc. | 334.68M | 1.49% | 1,091,974 | - |
| 271 | BCYC | Bicycle Therapeutics plc | 328.11M | 0.64% | 63,473 | 63.50M |
| 272 | FATE | Fate Therapeutics, Inc. | 321.70M | 4.94% | 2,057,522 | 6.32M |
| 273 | IRD | Opus Genetics, Inc. | 321.31M | 7.14% | 624,427 | 11.98M |
| 274 | SLN | Silence Therapeutics plc | 315.05M | -2.77% | 113,326 | 839.00K |
| 275 | NAGE | Niagen Bioscience, Inc. | 312.86M | 2.08% | 1,063,864 | 130.42M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 300.80M | -0.28% | 139,369 | 1.00 |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 300.17M | 0.74% | 50,851 | 5.20M |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 299.93M | 0.26% | 392,168 | - |
| 279 | HUMA | Humacyte, Inc. | 291.96M | 2.73% | 6,259,659 | 2.02M |
| 280 | SRZN | Surrozen, Inc. | 290.14M | -4.47% | 88,541 | 7.49M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 289.37M | 0.37% | 255,257 | 26.87M |
| 282 | CNXU | Conexeu Sciences Inc. | 283.02M | -3.28% | 26,861 | - |
| 283 | AVXL | Anavex Life Sciences Corp. | 280.33M | 2.89% | 525,485 | - |
| 284 | ACIU | AC Immune SA | 273.80M | 0.36% | 171,027 | 4.62M |
| 285 | MGNX | MacroGenics, Inc. | 270.45M | 1.07% | 161,563 | 157.08M |
| 286 | CLLS | Cellectis S.A. | 269.86M | -2.40% | 43,150 | 75.11M |
| 287 | TARA | Protara Therapeutics, Inc. | 263.60M | -1.26% | 293,818 | - |
| 288 | ALXO | ALX Oncology Holdings Inc. | 263.06M | 3.44% | 307,081 | - |
| 289 | ADAG | Adagene Inc. | 262.64M | 0.89% | 490,337 | 7.67M |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 260.29M | 5.77% | 22,294 | 18.47M |
| 291 | CNTX | Context Therapeutics Inc. | 259.10M | -0.35% | 187,787 | - |
| 292 | NVCT | Nuvectis Pharma, Inc. | 258.89M | -4.22% | 42,932 | - |
| 293 | CDXS | Codexis, Inc. | 256.33M | 2.55% | 517,666 | 78.09M |
| 294 | SABS | SAB Biotherapeutics, Inc. | 254.40M | 1.40% | 109,542 | 114.70K |
| 295 | CGEN | Compugen Ltd. | 253.96M | -3.42% | 205,594 | 72.66M |
| 296 | TRDA | Entrada Therapeutics, Inc. | 253.32M | 3.08% | 143,941 | 5.74M |
| 297 | FHTX | Foghorn Therapeutics Inc. | 253.06M | 0.94% | 55,802 | 28.22M |
| 298 | CHRS | Coherus Oncology, Inc. | 249.88M | -1.82% | 355,039 | 46.88M |
| 299 | ALEC | Alector, Inc. | 248.70M | 4.19% | 545,615 | 18.42M |
| 300 | LENZ | LENZ Therapeutics, Inc. | 248.64M | -0.75% | 422,442 | 20.99M |
| 301 | OBIO | Orchestra BioMed Holdings, Inc. | 236.83M | -0.63% | 73,445 | 32.72M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 234.29M | -0.84% | 130,324 | 7.15M |
| 303 | CRBU | Caribou Biosciences, Inc. | 232.87M | 2.60% | 939,183 | 11.20M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 232.32M | -1.41% | 262,442 | 36.49M |
| 305 | NKTX | Nkarta, Inc. | 231.81M | -1.82% | 201,748 | - |
| 306 | NERV | Minerva Neurosciences, Inc. | 231.08M | -0.80% | 29,895 | - |
| 307 | HELP | Cybin Inc. | 228.66M | 1.78% | 224,227 | - |
| 308 | RNA | Atrium Therapeutics, Inc. | 227.85M | -0.30% | 175,274 | 36.68M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 227.44M | -2.45% | 27,799 | 3.93M |
| 310 | YDES | YD Bio Limited | 227.13M | -7.98% | 11,629 | 510.36K |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 226.25M | 0.51% | 257,400 | 54.71M |
| 312 | KROS | Keros Therapeutics, Inc. | 224.44M | -0.44% | 63,341 | 33.18M |
| 313 | NGEN | NervGen Pharma Corp. | 219.84M | -0.48% | 722,531 | - |
| 314 | NBP | NovaBridge Biosciences | 213.95M | -1.07% | 212,165 | - |
| 315 | RNAC | Cartesian Therapeutics, Inc. | 212.43M | 0.28% | 161,238 | 1.78M |
| 316 | IMUX | Immunic, Inc. | 208.82M | 2.40% | 190,635 | - |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 204.54M | -0.44% | 142,113 | 151.12M |
| 318 | ELTX | Elicio Therapeutics, Inc. | 203.64M | 4.34% | 44,672 | - |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.35M | -2.06% | 276,694 | 17.56M |
| 320 | UNCY | Unicycive Therapeutics, Inc. | 197.31M | 5.27% | 379,978 | - |
| 321 | MIST | Milestone Pharmaceuticals Inc. | 196.59M | 0.35% | 308,209 | 1.78M |
| 322 | ENLV | Enlivex Ltd. | 195.35M | 6.02% | 640,688 | - |
| 323 | KRRO | Korro Bio, Inc. | 188.14M | -2.65% | 73,727 | 3.84M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 187.43M | 2.17% | 104,972 | - |
| 325 | EQ | Equillium, Inc. | 187.15M | 4.23% | 537,792 | 4.39M |
| 326 | MDWD | MediWound Ltd. | 186.74M | -0.21% | 107,809 | 14.48M |
| 327 | INDP | Indaptus Therapeutics, Inc. | 183.45M | 12.50% | 29,846 | - |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 182.60M | 5.33% | 2,999,667 | 225.00K |
| 329 | TLSA | Tiziana Life Sciences Ltd | 182.32M | -3.42% | 167,564 | - |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 180.45M | 2.41% | 489,686 | - |
| 331 | DTIL | Precision BioSciences, Inc. | 180.10M | 0.87% | 168,228 | 45.07M |
| 332 | QTTB | Q32 Bio Inc. | 179.74M | 2.81% | 905,718 | 53.74M |
| 333 | IPHA | Innate Pharma S.A. | 176.66M | 11.49% | 4,851 | 10.57M |
| 334 | OKUR | OnKure Therapeutics, Inc. | 173.30M | 4.13% | 53,638 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 170.41M | 0.71% | 318,393 | 76.38M |
| 336 | PRQR | ProQR Therapeutics N.V. | 168.58M | 1.91% | 251,972 | 15.73M |
| 337 | GALT | Galectin Therapeutics Inc. | 166.62M | -1.56% | 193,833 | - |
| 338 | MENS | Jyong Biotech Ltd. | 164.80M | -1.33% | 16,952 | - |
| 339 | HRTX | Heron Therapeutics, Inc. | 163.20M | -3.33% | 895,161 | 150.71M |
| 340 | NRXP | NRx Pharmaceuticals, Inc. | 162.88M | 1.35% | 768,795 | 2.29M |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 162.68M | 0.38% | 82,011 | 2.00M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 161.98M | 0.90% | 54,794 | - |
| 343 | SPRO | Spero Therapeutics, Inc. | 161.55M | -3.79% | 943,161 | 61.19M |
| 344 | PLYX | Polaryx Therapeutics, Inc. | 160.49M | 11.15% | 404,957 | - |
| 345 | TTRX | Turn Therapeutics Inc. | 149.98M | -5.18% | 118,945 | - |
| 346 | MOLN | Molecular Partners AG | 146.93M | 4.92% | 937 | 856.30K |
| 347 | KZIA | Kazia Therapeutics Limited | 146.61M | 1.26% | 68,189 | 1.27M |
| 348 | HURA | TuHURA Biosciences, Inc. | 143.92M | -3.83% | 250,151 | - |
| 349 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.83M | 3.93% | 586,125 | - |
| 350 | AGEN | Agenus Inc. | 139.78M | -1.03% | 371,331 | 123.87M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 136.22M | 1.26% | 59,101 | 233.00K |
| 352 | GNLX | Genelux Corporation | 135.00M | -0.98% | 66,046 | 8.00K |
| 353 | SPRB | Spruce Biosciences, Inc. | 134.06M | 0.85% | 23,046 | 697.00K |
| 354 | GUTS | Fractyl Health, Inc. | 130.14M | -2.46% | 1,345,953 | 3.00K |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 130.08M | 0.89% | 1,128,270 | 70.00M |
| 356 | ACOG | Alpha Cognition Inc. | 128.25M | -0.84% | 81,546 | 10.83M |
| 357 | CRDF | Cardiff Oncology, Inc. | 125.80M | - | 363,305 | 525.00K |
| 358 | ENGN | enGene Therapeutics Inc. | 123.26M | 3.37% | 681,073 | - |
| 359 | KLRS | Kalaris Therapeutics, Inc. | 123.01M | 3.28% | 32,359 | - |
| 360 | ONCY | Oncolytics Biotech Inc. | 121.93M | 12.30% | 1,924,477 | - |
| 361 | ALPS | Alps Group Inc | 121.76M | -4.97% | 10,611 | 3.74M |
| 362 | NTHI | NeOnc Technologies Holdings, Inc. | 116.96M | -3.55% | 19,854 | 39.99K |
| 363 | PYXS | Pyxis Oncology, Inc. | 113.41M | 0.56% | 210,397 | 13.86M |
| 364 | CBUS | Cibus, Inc. | 112.52M | 1.72% | 135,202 | 3.64M |
| 365 | VANI | Vivani Medical, Inc. | 112.11M | 0.78% | 59,751 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 111.89M | -1.24% | 89,323 | 7.94M |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 108.98M | 2.31% | 604,554 | 65.34K |
| 368 | CGTX | Cognition Therapeutics, Inc. | 106.78M | 0.42% | 495,947 | - |
| 369 | SEER | Seer, Inc. | 106.64M | -2.07% | 73,449 | 16.58M |
| 370 | PEPG | PepGen Inc. | 105.48M | 1.67% | 320,936 | - |
| 371 | RNTX | Rein Therapeutics Inc. | 104.20M | 0.90% | 404,138 | - |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 102.85M | -2.57% | 273,557 | - |
| 373 | VRCA | Verrica Pharmaceuticals Inc. | 101.96M | -1.66% | 15,603 | 37.16M |
| 374 | PMN | ProMIS Neurosciences, Inc. | 100.53M | 3.13% | 27,833 | - |
| 375 | BMEA | Biomea Fusion, Inc. | 100.50M | 0.72% | 361,327 | - |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 96.82M | 1.94% | 588,312 | 3.17M |
| 377 | ACET | Adicet Bio, Inc. | 95.77M | 5.56% | 94,475 | - |
| 378 | OSTX | OS Therapies Incorporated | 95.31M | 8.08% | 747,180 | - |
| 379 | FBIO | Fortress Biotech, Inc. | 94.01M | 0.71% | 241,427 | 66.16M |
| 380 | ICCC | ImmuCell Corporation | 93.09M | 3.94% | 12,001 | 29.93M |
| 381 | ANIX | Anixa Biosciences, Inc. | 92.20M | 1.85% | 66,903 | - |
| 382 | LONA | LeonaBio, Inc. | 91.40M | 0.93% | 3,980 | - |
| 383 | PYPD | PolyPid Ltd. | 90.84M | - | 27,637 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 90.37M | 0.78% | 1,886 | 27.70M |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 89.89M | -6.22% | 59,710 | 23.14M |
| 386 | OKYO | OKYO Pharma Limited | 89.74M | - | 22,564 | - |
| 387 | AARD | Aardvark Therapeutics, Inc. | 89.45M | -2.38% | 76,279 | - |
| 388 | OTLK | Outlook Therapeutics, Inc. | 88.17M | -1.42% | 25,685,246 | 333.14K |
| 389 | HYFT | MindWalk Holdings Corp. | 88.16M | -0.84% | 232,993 | 20.70M |
| 390 | NRXS | NeurAxis, Inc. | 83.53M | -0.41% | 38,447 | 4.28M |
| 391 | EXOZ | eXoZymes, Inc. | 83.48M | 1.29% | 3,748 | -700.00 |
| 392 | ANVS | Annovis Bio, Inc. | 83.17M | 2.89% | 715,600 | - |
| 393 | CSBR | Champions Oncology, Inc. | 82.35M | 1.37% | 2,075 | 57.95M |
| 394 | GANX | Gain Therapeutics, Inc. | 82.32M | -4.46% | 599,818 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 78.43M | - | 346,976 | - |
| 396 | PLRX | Pliant Therapeutics, Inc. | 77.71M | 0.40% | 128,319 | - |
| 397 | RLYB | Rallybio Corporation | 77.36M | 0.72% | 23,697 | 858.00K |
| 398 | XBIT | XBiotech Inc. | 74.09M | -0.41% | 33,729 | - |
| 399 | FLNA | Filana Therapeutics, Inc. | 73.43M | -1.93% | 228,620 | - |
| 400 | MCRB | Seres Therapeutics, Inc. | 72.73M | -0.92% | 24,797 | 1.15M |
| 401 | CUE | Cue Biopharma, Inc. | 72.66M | -1.41% | 42,814 | 32.73M |
| 402 | TCRX | TScan Therapeutics, Inc. | 71.89M | 1.85% | 146,408 | 9.14M |
| 403 | LIXT | Lixte Biotechnology Holdings, Inc. | 71.57M | 2.84% | 10,951 | - |
| 404 | BYSI | BeyondSpring Inc. | 70.73M | - | 15,137 | 1.88M |
| 405 | ATHE | Alterity Therapeutics Limited | 70.07M | -1.47% | 18,619 | 4.43M |
| 406 | IBIO | iBio, Inc. | 69.03M | -1.04% | 232,516 | 300.00K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 68.91M | -1.23% | 229,648 | - |
| 408 | MNOV | MediciNova, Inc. | 65.97M | -2.17% | 22,401 | 596.64K |
| 409 | IMA | ImageneBio, Inc. | 65.93M | -1.35% | 506 | 800.00K |
| 410 | EDSA | Edesa Biotech, Inc. | 64.78M | -7.25% | 175,562 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 64.00M | 0.84% | 305,401 | - |
| 412 | ENTX | Entera Bio Ltd. | 62.27M | 3.69% | 59,898 | 42.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 61.08M | 0.49% | 51,826 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 60.28M | 0.93% | 502,209 | - |
| 415 | DWTX | Dogwood Therapeutics, Inc. | 56.45M | 1.20% | 19,296 | - |
| 416 | IMMP | Immutep Limited | 55.92M | -0.79% | 407,630 | 5.28M |
| 417 | CING | Cingulate Inc. | 55.89M | -3.00% | 722,445 | - |
| 418 | MREO | Mereo BioPharma Group plc | 55.87M | 1.45% | 3,072,752 | 500.00K |
| 419 | IBO | Impact BioMedical Inc. | 55.43M | - | 21,009 | 39.00K |
| 420 | TIL | Instil Bio, Inc. | 55.00M | 0.12% | 9,057 | - |
| 421 | ATYR | aTyr Pharma, Inc. | 53.84M | 12.66% | 4,291,920 | 190.00K |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 51.58M | -2.14% | 140,879 | 22.33M |
| 423 | HYPD | Hyperion DeFi, Inc. | 50.86M | 4.07% | 512,777 | 1.04M |
| 424 | RADX | Radiopharm Theranostics Limited | 50.75M | -1.57% | 8,164 | 10.86M |
| 425 | XLO | Xilio Therapeutics, Inc. | 49.78M | -2.35% | 13,986 | 53.48M |
| 426 | ACTU | Actuate Therapeutics, Inc. | 49.77M | - | 72,830 | - |
| 427 | GOSS | Gossamer Bio, Inc. | 49.66M | 0.24% | 6,262,032 | 55.54M |
| 428 | ESLA | Estrella Immunopharma, Inc. | 49.06M | - | 5,847 | - |
| 429 | QNTM | Quantum BioPharma Ltd. | 45.19M | -0.43% | 122,048 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 1.56% | 97,726 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 43.90M | -1.77% | 15,111 | - |
| 432 | RNXT | RenovoRx, Inc. | 42.35M | -4.95% | 223,055 | 1.49M |
| 433 | KALA | KALA BIO, Inc. | 41.73M | -1.97% | 47,154 | - |
| 434 | PSTV | Plus Therapeutics, Inc. | 41.72M | -5.44% | 122,176 | 5.21M |
| 435 | NTRB | Nutriband Inc. | 41.56M | -6.21% | 5,925 | 2.04M |
| 436 | LTRN | Lantern Pharma Inc. | 39.79M | 1.43% | 72,276 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 39.30M | 4.53% | 168,157 | - |
| 438 | NNVC | NanoViricides, Inc. | 39.18M | -7.53% | 735,982 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 38.97M | 8.70% | 94,761 | 90.00K |
| 440 | VERU | Veru Inc. | 37.34M | 0.28% | 19,618 | 16.89M |
| 441 | INMB | INmune Bio Inc. | 37.09M | -1.76% | 211,024 | 50.00K |
| 442 | GRDX | GridAI Technologies Corp. | 36.54M | 10.96% | 86,733 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 35.58M | -0.69% | 66,426 | 4.71M |
| 444 | ABVC | ABVC BioPharma, Inc. | 35.13M | -1.40% | 52,363 | 797.92K |
| 445 | LITS | Lite Strategy, Inc. | 34.88M | 0.49% | 205,395 | - |
| 446 | DARE | Daré Bioscience, Inc. | 33.96M | -0.56% | 94,590 | 1.16M |
| 447 | EVAX | Evaxion A/S | 33.53M | -1.95% | 14,621 | 7.53M |
| 448 | PLRZ | Polyrizon Ltd. | 32.71M | 5.91% | 32,307 | - |
| 449 | TVGN | Tevogen Bio Holdings Inc. | 32.46M | -3.57% | 22,347 | - |
| 450 | BOLD | Boundless Bio, Inc. | 32.28M | -1.37% | 31,129 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 31.71M | -3.15% | 30,267 | - |
| 452 | APLM | Apollomics, Inc. | 31.07M | 0.64% | 20,120 | 8.84M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 30.71M | -1.40% | 104,712 | 38.00K |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 29.69M | -2.33% | 98,064 | - |
| 455 | CRVO | CervoMed Inc. | 28.96M | -0.38% | 59,364 | 2.09M |
| 456 | CELU | Celularity Inc. | 28.95M | 0.91% | 42,729 | 26.55M |
| 457 | LSTA | Lisata Therapeutics, Inc. | 28.55M | -4.23% | 92,708 | 170.00K |
| 458 | NEUP | Neuphoria Therapeutics Inc. | 28.37M | -2.05% | 16,266 | -13.27K |
| 459 | DYAI | Dyadic International, Inc. | 28.27M | 9.27% | 492,941 | 3.81M |
| 460 | IGC | IGC Pharma, Inc. | 28.26M | -1.28% | 199,694 | 1.11M |
| 461 | KYNB | Kyntra Bio, Inc. | 28.11M | -1.07% | 4,478 | 7.44M |
| 462 | SNSE | Sensei Biotherapeutics, Inc. | 27.95M | 18.42% | 50,736 | - |
| 463 | SER | Serina Therapeutics, Inc. | 27.93M | -3.85% | 29,282 | 130.00K |
| 464 | BRNS | Barinthus Biotherapeutics plc | 27.88M | -0.10% | 1,779 | 14.97M |
| 465 | PTN | Palatin Technologies, Inc. | 27.53M | 1.93% | 5,982 | 12.88M |
| 466 | SKYE | Skye Bioscience, Inc. | 27.24M | -8.75% | 235,479 | - |
| 467 | MRKR | Marker Therapeutics, Inc. | 26.26M | 4.30% | 81,852 | 3.55M |
| 468 | BCTX | BriaCell Therapeutics Corp. | 26.21M | 0.98% | 104,519 | - |
| 469 | PLUR | Pluri Inc. | 25.89M | 2.13% | 24,868 | 1.08M |
| 470 | ALLR | Allarity Therapeutics, Inc. | 25.66M | -0.60% | 158,123 | 345.00K |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 25.13M | 0.16% | 442,267 | 789.00K |
| 472 | CLRB | Cellectar Biosciences, Inc. | 24.69M | -1.59% | 162,833 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 23.91M | -4.09% | 232,674 | - |
| 474 | GNTA | Genenta Science S.p.A. | 23.23M | 10.04% | 727,088 | - |
| 475 | VYNE | VYNE Therapeutics Inc. | 22.87M | -0.09% | 52,496 | 454.00K |
| 476 | KTTA | Pasithea Therapeutics Corp. | 22.81M | -1.83% | 365,331 | - |
| 477 | LGVN | Longeveron Inc. | 22.69M | -4.90% | 134,244 | 1.22M |
| 478 | CVM | CEL-SCI Corporation | 22.61M | 5.41% | 150,817 | - |
| 479 | NXTC | NextCure, Inc. | 22.35M | -3.20% | 4,798 | - |
| 480 | TPST | Tempest Therapeutics, Inc. | 22.23M | -10.40% | 187,616 | - |
| 481 | TRAW | Traws Pharma, Inc. | 22.12M | -3.95% | 249,299 | 2.73M |
| 482 | HOWL | Werewolf Therapeutics, Inc. | 21.87M | -1.32% | 205,528 | 1.14M |
| 483 | CRIS | Curis, Inc. | 21.01M | 0.42% | 93,990 | 7.06M |
| 484 | XCUR | Exicure, Inc. | 20.14M | 6.40% | 11,139 | 500.00K |
| 485 | QNCX | Quince Therapeutics, Inc. | 19.32M | 1.28% | 492,813 | - |
| 486 | AEON | AEON Biopharma, Inc. | 19.22M | 2.00% | 23,886 | - |
| 487 | AKTX | Akari Therapeutics, Plc | 19.17M | -24.04% | 450,791 | - |
| 488 | PASG | Passage Bio, Inc. | 18.77M | 2.45% | 19,555 | - |
| 489 | NCEL | NewcelX Ltd. | 18.52M | -2.82% | 19,386 | - |
| 490 | LPCN | Lipocine Inc. | 18.30M | 0.88% | 64,933 | 2.00M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 18.25M | 1.82% | 281,482 | 5.61M |
| 492 | INAB | IN8bio, Inc. | 17.82M | 0.56% | 23,385 | - |
| 493 | GTBP | GT Biopharma, Inc. | 17.34M | 7.95% | 2,460,135 | - |
| 494 | HIND | Vyome Holdings, Inc. | 16.56M | 0.43% | 13,629 | 152.72K |
| 495 | MLEC | Moolec Science SA | 15.97M | 6.60% | 25,548 | 7.83M |
| 496 | OSRH | OSR Holdings, Inc. | 15.57M | -3.57% | 906,550 | 2.63M |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 15.45M | 0.40% | 20,500 | - |
| 498 | COCP | Cocrystal Pharma, Inc. | 15.44M | -0.88% | 78,621 | 225.00K |
| 499 | MTVA | MetaVia Inc. | 15.29M | -4.52% | 887,735 | - |
| 500 | LEXX | Lexaria Bioscience Corp. | 14.75M | -4.05% | 45,369 | 368.00K |